4//SEC Filing
Clearside Biomedical, Inc. 4
Accession 0001209191-17-039986
$CLSDQCIK 0001539029operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:54 PM ET
Size
14.0 KB
Accession
0001209191-17-039986
Insider Transaction Report
Form 4
White Daniel H.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2017-06-13$7.78/sh−3,600$28,008→ 504,067 total - Sale
Common Stock
2017-06-14$7.99/sh−400$3,196→ 38,509 total(indirect: By Trust) - Sale
Common Stock
2017-06-14$7.99/sh−3,600$28,764→ 500,467 total - Sale
Common Stock
2017-06-13$7.78/sh−400$3,112→ 38,909 total(indirect: By Trust)
Holdings
- 301(indirect: As UTMA custodian for son)
Common Stock
- 844(indirect: As UTMA custodian for son)
Common Stock
- 1,188(indirect: As UTMA custodian for son)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holders of the securities on March 16, 2017.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.61 to $8.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $7.72 to $8.27, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F4]These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F5]These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001539029
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 7:54 PM ET
- Size
- 14.0 KB